News

We are taking a look back at the top articles published in Contagion®’s print journal in 2019.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of December 29, 2019.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Treating parents colonized with S aureus reduced neonatal colonization with concordant S aureus strains when compared to placebo.

According to a new report issued by the WHO, the global incidence of cholera cases decreased by 60% in 2018.

A new study published in the Journal of Clinical Investigation may offer some insight on why past efforts to develop a vaccine for S aureus have failed.

The Bacille Calmette-Geurin vaccine is typically administered intradermally, which may not generate enough T cells to elicit strong immune responses in the lungs to effectively protect against TB.

Exploring the antibiotic commercial conundrum. ​

Investigators of a new, multisite study evaluating neuropsychological development in African school-age kids found that children with perinatally-acquired HIV had poorer results on neuropsychological tests despite early ART initiation and viral suppression.

A recent study published in Transgender Health analyzed transgender and gender-nonconforming ART adherence based on the US Trans Survey, the largest survey of TGNC people in the United States.

As December draws to a close, the Contagion® editorial team is recapping the trends and top infectious disease news of the month.

Stay up-to-date on the top infectious disease news by checking out our top 5 articles of the year.

Even as hospitals try to stop health care-associated illnesses, they can often have difficulty identifying which employees are too sick to work. New research suggests a high number of health care employees work while experiencing symptoms of illness.

A recent commentary discusses the need to uncover diagnostic and prognostic biomarkers for HIV-associated neurocognitive disorder (HAND).

Here is a look back at approvals, clearances, and authorizations granted by the US Food and Drug Administration for infectious disease products in 2019.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of December 22, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

A study sheds light on the challenges we need to account for in treating neglected tropical diseases.

Contagion® counts down the top HIV news stories of 2019, including FDA approvals, breakthrough discoveries, recommendations from the frontlines, and a big-picture look at just how close we are to ending the epidemic.

A new study out of Africa demonstrates that maternal-child clinics may act as a one-stop shop for both pregnancy and postpartum concerns and HIV protection.

From Ebola to measles to Salmonella, these were the top 9 infectious disease outbreaks of 2019.

Study finds coinfection is unlikely as Europe braces for influenza A.

Pharmacists have the opportunity to take a lead role in providing education on the importance of vaccines in protecting people from preventable illnesses, according to a session which took place at the American Society of Health-System Pharmacists (ASHP) 54th Midyear Clinical Meeting & Exhibition.

Rapid diagnostic tests provide a potential alternative for diagnosis of Chagas disease in the context of material constraints.

A retrospective study sought answers about infection treatment with the combination antimicrobial ceftazidime-avibactam.

Combining financial incentives and accelerated vaccine schedules may improve hepatitis B vaccination completion among people who inject drugs who are at high risk for the infection, according to a new study.

Contagion® radio is here to bring joy with every new antibiotic alert!